Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional Results available

Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plus Standard Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC), ARCHON-1 Trial

ClinicalTrials.gov ID: NCT03801902

Public ClinicalTrials.gov record NCT03801902. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 11:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase I Trial of Radiotherapy Combined With Durvalumab Alone Plus Either Monalizumab or Oleclumab in PD-L1 High Locally Advanced Non-Small Cell Lung Cancer (NSCLC) (ARCHON-1)

Study identification

NCT ID
NCT03801902
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
National Cancer Institute (NCI)
NIH
Enrollment
26 participants

Conditions and interventions

Interventions

  • Accelerated Hypofractionated Radiation Therapy Radiation
  • Biospecimen Collection Procedure
  • Computed Tomography Procedure
  • Durvalumab Biological
  • Magnetic Resonance Imaging of the Brain with and without Contrast Procedure
  • Monalizumab Biological
  • Oleclumab Biological
  • Radiation Therapy Radiation

Radiation · Procedure · Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 27, 2019
Primary completion
Oct 25, 2021
Completion
Sep 3, 2025
Last update posted
Sep 22, 2025

2019 – 2025

United States locations

U.S. sites
56
U.S. states
16
U.S. cities
45
Facility City State ZIP Site status
Grady Health System Atlanta Georgia 30303
Emory University Hospital Midtown Atlanta Georgia 30308
Emory University Hospital/Winship Cancer Institute Atlanta Georgia 30322
Emory Saint Joseph's Hospital Atlanta Georgia 30342
Augusta University Medical Center Augusta Georgia 30912
Saint Alphonsus Cancer Care Center-Boise Boise Idaho 83706
Saint Alphonsus Cancer Care Center-Caldwell Caldwell Idaho 83605
Saint Alphonsus Cancer Care Center-Nampa Nampa Idaho 83687
University of Kansas Cancer Center-West Kansas City Kansas 66112
University of Kansas Cancer Center Kansas City Kansas 66160
University of Kansas Cancer Center-Overland Park Overland Park Kansas 66210
University of Kansas Hospital-Westwood Cancer Center Westwood Kansas 66205
Saint Elizabeth Healthcare Edgewood Edgewood Kentucky 41017
University of Maryland/Greenebaum Cancer Center Baltimore Maryland 21201
UM Upper Chesapeake Medical Center Bel Air Maryland 21014
Central Maryland Radiation Oncology in Howard County Columbia Maryland 21044
UM Baltimore Washington Medical Center/Tate Cancer Center Glen Burnie Maryland 21061
McLaren Cancer Institute-Bay City Bay City Michigan 48706
McLaren Cancer Institute-Clarkston Clarkston Michigan 48346
Michigan Healthcare Professionals Clarkston Clarkston Michigan 48346
Wayne State University/Karmanos Cancer Institute Detroit Michigan 48201
Michigan Healthcare Professionals Farmington Farmington Hills Michigan 48334
Weisberg Cancer Treatment Center Farmington Hills Michigan 48334
McLaren Cancer Institute-Flint Flint Michigan 48532
Singh and Arora Hematology Oncology PC Flint Michigan 48532
Karmanos Cancer Institute at McLaren Greater Lansing Lansing Michigan 48910
Mid-Michigan Physicians-Lansing Lansing Michigan 48912
McLaren Cancer Institute-Lapeer Region Lapeer Michigan 48446
McLaren Cancer Institute-Macomb Mount Clemens Michigan 48043
McLaren Cancer Institute-Northern Michigan Petoskey Michigan 49770
McLaren-Port Huron Port Huron Michigan 48060
Michigan Healthcare Professionals Troy Troy Michigan 48098
Siteman Cancer Center at Saint Peters Hospital City of Saint Peters Missouri 63376
Siteman Cancer Center at West County Hospital Creve Coeur Missouri 63141
University of Kansas Cancer Center - North Kansas City Missouri 64154
University of Kansas Cancer Center - Lee's Summit Lee's Summit Missouri 64064
University of Kansas Cancer Center at North Kansas City Hospital North Kansas City Missouri 64116
Washington University School of Medicine St Louis Missouri 63110
Siteman Cancer Center-South County St Louis Missouri 63129
Siteman Cancer Center at Christian Hospital St Louis Missouri 63136
Benefis Sletten Cancer Institute Great Falls Montana 59405
Logan Health Medical Center Kalispell Montana 59901
Nebraska Methodist Hospital Omaha Nebraska 68114
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104
Legacy Mount Hood Medical Center Gresham Oregon 97030
Legacy Good Samaritan Hospital and Medical Center Portland Oregon 97210
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107
Lankenau Medical Center Wynnewood Pennsylvania 19096
MD Anderson in The Woodlands Conroe Texas 77384
M D Anderson Cancer Center Houston Texas 77030
MD Anderson West Houston Houston Texas 77079
MD Anderson League City League City Texas 77573
MD Anderson in Sugar Land Sugar Land Texas 77478
Legacy Salmon Creek Hospital Vancouver Washington 98686
West Virginia University Healthcare Morgantown West Virginia 26506

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03801902, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 22, 2025 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03801902 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →